D. Medical (DMED) Gets CE Mark for Spring Zone IDS
Tweet
Share
E-mail
D. Medical Industries Ltd. (Nasdaq: DMED) announced that the Company, through its wholly owned subsidiary Spring Health Solution Ltd., received a CE Mark approval for its Spring Zone Insulin Delivery System. "Spring Zone" replaces D. Medical's first generation Spring ADI insulin pump.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Kimbell Royalty closes $221.2M mineral rights acquisition
- Real and RE/MAX Holdings receive court approval for merger
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
